ADR-002K

· Rohto Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ADR-002K, covering 2025-09-25 to 2025-09-25. Get the full timeline:

Most recent: Clinical Trial Update: Exploratory Study of ADR-002K for Heart Failure Patients With Ischemic Heart Disease Who Undergo CABG [Phase 2]